AI assistant
Sending…
Century Therapeutics, Inc. — Director's Dealing 2024
Jul 31, 2024
34658_dirs_2024-07-31_9c6c132b-3dc6-44e6-98b1-8236c5c23e3f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Century Therapeutics, Inc. (IPSC)
CIK: 0001850119
Period of Report: 2024-07-26
Reporting Person: Russotti Gregory (See Remarks)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-07-26 | Common Stock | S | 586 | $2.5 | Disposed | 274933 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 92773 | Indirect |
Footnotes
F1: The transactions reported herein were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 9, 2024.
More from Century Therapeutics, Inc.
Regulatory Filings
2026
May 21
Regulatory Filings
2026
May 13
Interim / Quarterly Report
2026
May 13
Proxy Solicitation & Information Statement
2026
Apr 27
Director's Dealing
2026
Feb 18
Major Shareholding Notification
2026
Feb 17
Director's Dealing
2026
Feb 5
Regulatory Filings
2026
Feb 5
Director's Dealing
2026
Feb 4
Director's Dealing
2026
Feb 4